1. Home
  2. ADAG vs SAMG Comparison

ADAG vs SAMG Comparison

Compare ADAG & SAMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAG
  • SAMG
  • Stock Information
  • Founded
  • ADAG 2011
  • SAMG 2002
  • Country
  • ADAG China
  • SAMG United States
  • Employees
  • ADAG N/A
  • SAMG N/A
  • Industry
  • ADAG Biotechnology: Pharmaceutical Preparations
  • SAMG Investment Managers
  • Sector
  • ADAG Health Care
  • SAMG Finance
  • Exchange
  • ADAG Nasdaq
  • SAMG Nasdaq
  • Market Cap
  • ADAG 110.8M
  • SAMG 129.5M
  • IPO Year
  • ADAG 2021
  • SAMG 2013
  • Fundamental
  • Price
  • ADAG $1.95
  • SAMG $15.05
  • Analyst Decision
  • ADAG Strong Buy
  • SAMG
  • Analyst Count
  • ADAG 3
  • SAMG 0
  • Target Price
  • ADAG $7.67
  • SAMG N/A
  • AVG Volume (30 Days)
  • ADAG 60.8K
  • SAMG 27.5K
  • Earning Date
  • ADAG 08-12-2025
  • SAMG 10-30-2025
  • Dividend Yield
  • ADAG N/A
  • SAMG 5.60%
  • EPS Growth
  • ADAG N/A
  • SAMG N/A
  • EPS
  • ADAG N/A
  • SAMG 0.87
  • Revenue
  • ADAG $103,204.00
  • SAMG $124,451,000.00
  • Revenue This Year
  • ADAG $7,411.34
  • SAMG $4.77
  • Revenue Next Year
  • ADAG $28.29
  • SAMG $6.77
  • P/E Ratio
  • ADAG N/A
  • SAMG $17.25
  • Revenue Growth
  • ADAG N/A
  • SAMG 4.13
  • 52 Week Low
  • ADAG $1.33
  • SAMG $13.54
  • 52 Week High
  • ADAG $3.16
  • SAMG $19.20
  • Technical
  • Relative Strength Index (RSI)
  • ADAG 44.56
  • SAMG 33.22
  • Support Level
  • ADAG $1.85
  • SAMG $15.11
  • Resistance Level
  • ADAG $2.06
  • SAMG $15.51
  • Average True Range (ATR)
  • ADAG 0.11
  • SAMG 0.34
  • MACD
  • ADAG -0.01
  • SAMG -0.09
  • Stochastic Oscillator
  • ADAG 26.08
  • SAMG 2.88

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

Share on Social Networks: